Ecoatoms Inc. — Three FO Projects (Biosensors, HERMES, ANIMA)¶
FO Projects:
- 106609 In-Space Biosensors Batch Coating Using Self-Assembled Monolayers — TRL 4→6, Dec 2021–Dec 2026
- 184148 HERMES (Hardware for Extraction and Reagent Mixing) — TRL 4→9, active
- 158510 ANIMA (Apparatus for Nominal Integration with Minimal Adaptations) — TRL 2→8, active
Views: 3,129 (biosensors) + 1,574 (HERMES) + 2,606 (ANIMA) = 7,309 total across 3 projects
Outcome category: Active multi-flight pipeline — 2 TechLeap Prize wins; 3 flights completed (NS-24, Transporter-14, NS-35); pre-commercial
Federal $ tracked: ~$224K (Space Act Agreement) — no USASpending contracts found
Investment: SSBCI Venture Capital Program (Nevada state VC, early investor)
Confidence: confirmed (flights, TechLeap), speculative (commercial outcome)
Company Overview¶
Ecoatoms is a space manufacturing company based in Reno, NV (originally San Francisco/Atherton, CA) focused on in-space batch production and on-board computers. They describe themselves as developing "payloads designed to manufacture materials and test a variety of products in space." They appeared at CES 2025 and SpaceCom 2026.
PI/CEO: Solange Massa, MD PhD — Harvard-MIT Health Sciences & Technology (pioneered Organ-on-a-Chip platforms), Stanford postdoctoral fellow (radiation-induced diseases), MIT Innovator Under 35, former Lead Investment Fellow at Life Science Angels. OIST Japan fireside chat speaker. Director of the newly established Aerospace and Defense Academy at UNR Ozmen Center for Entrepreneurship (2024). The founder's medical/biotech background explains the biosensor and genetic extraction focus.
Co-investigators: Aram Garibyan (HERMES), Pablo Echavarria (ANIMA)
Institutional infrastructure: Uses UNR Makerspace for 3D printing; operates BSL-2 wet lab, dry lab, and prototyping facility via NCAR (Nevada Center for Applied Research) affiliation.
Ecoatoms is notable for having three simultaneous FO projects and three completed flights (NS-24, Transporter-14, NS-35) — an unusually deep NASA engagement for an early-stage startup.
Project 1: Biosensors [106609] — In-Space Coating for Electrochemical Sensors¶
Period: Dec 2021 – Dec 2026 (5-year project)
TRL: 4 → 6 (target)
Views: 3,129
What it tests: Whether microgravity allows self-assembled monolayers (SAMs) to form more uniformly on biosensor surfaces than on Earth. On Earth, gravity causes convection and sedimentation that disrupts SAM formation. In microgravity, the theory is that SAM layers will be smoother, more uniform, and therefore more sensitive/specific as electrochemical sensors.
Application: Point-of-care diagnostics in space (glucose monitoring, molecular analyte detection without lab equipment). Relevant for long-duration missions where crew health monitoring requires portable, reliable biosensors.
Flight platform: Blue Origin New Shepard
- Flight 1: NS-24 (December 19, 2023) — first Ecoatoms flight. Batch-manufacturing payload including biosensors and medical devices with 3D-printed components from UNR Makerspace. Altitude: 351,248 ft. Described as "successfully deployed" by NASA.
- Flight 2: NS-35 (August 23, 2025) — "A.R.E.S." (Autonomous Research Experiment in Space). 432 biosensors coated simultaneously in microgravity. Powered by ANIMA onboard computer — meaning ANIMA has already flown, not just targeted for future.
CORRECTION (Session 72): The KB previously stated NS-35 was the first Ecoatoms flight. In fact, biosensors first flew on NS-24 (Dec 2023), and A.R.E.S. on NS-35 was the second suborbital flight. The NS-35 date was also incorrectly listed as Sep 18 — it launched Aug 23, 2025.
Space Act Agreement: $224,013 (Aug 2025 – Aug 2026) for Space Technology Payload Challenge integration.
Post-flight analysis presumably ongoing — TechPort still shows TRL 4 (not yet updated to reflect flight results).
Project 2: HERMES [184148] — Automated Genetic Extraction¶
Period: Active (2025-2027)
TRL: 4 → 9 (target — ambitious)
Views: 1,574
What it tests: HERMES automates genetic material extraction from biological samples in space, significantly reducing astronaut time on R&D procedures. The system targets NASA's General-Purpose Robotic Manipulator interface — it's designed to be robotically operated.
TechLeap Prize winner (2025): NASA selected 10 winning teams for the Space Technology Payload Challenge. Ecoatoms won, receiving up to $500K prize + flight test opportunity (target: summer 2026 aboard suborbital vehicle, rocket-powered lander, or orbital vehicle).
Application: In-space genomics — gene expression analysis, microbiome monitoring, rapid pathogen detection for crew health. Critical for long-duration missions (Moon, Mars) where Earth-based lab analysis is impractical.
Note: The UNR article (2024) credits the TechLeap Prize to ANIMA, not HERMES. This may indicate Ecoatoms won TechLeap in two rounds (ANIMA in 2024, HERMES in 2025), or there is conflicting reporting. Both projects have TechLeap-aligned timelines.
Project 3: ANIMA [158510] — Universal Payload Integration Adapter¶
Period: Active
TRL: 2 → 8 (target — very ambitious)
Views: 2,606
What it tests: ANIMA is a modular experiment and payload adapter designed to enable simple, rapid, interchangeable integration onto host vehicles. Combines mounting, power, and C&DH (command, data, handling) in a standardized interface.
Application: The "payload adapter problem" — different vehicles (Blue Origin, Virgin Galactic, Rocket Lab, SpacePlane variants) have different interfaces, making payload integration expensive and time-consuming. ANIMA aims to be a universal adapter layer, reducing integration cost and enabling rapid multi-vehicle access.
Non-FO Flight: The Exploration Company / SpaceX Transporter-14 (Orbital)¶
Date: June 23, 2025 (Vandenberg SFB)
Vehicle: SpaceX Falcon 9 → The Exploration Company Nyx reusable capsule
Payload: Organisms for biological behavior study in extreme conditions (lunar-relevant)
This is Ecoatoms' first orbital flight and demonstrates capability beyond suborbital FO testing. The Exploration Company (French-German startup) builds Nyx, a reusable orbital capsule. Ecoatoms' partnership here is separate from the NASA FO program — it's a commercial payload integration on a European vehicle.
Assessment¶
Pattern (updated Session 72): Ecoatoms has pivoted from "multi-project startup with no flights" to "multi-flight company with 3 completed missions." The cadence — NS-24 (Dec 2023), Transporter-14 (Jun 2025), NS-35 (Aug 2025) — shows 3 flights in 20 months, which is aggressive for a small startup.
Key evolution since Session 49: 1. ANIMA has already flown — it powered A.R.E.S. on NS-35 as the onboard computer. This means ANIMA is no longer TRL 2; it has flight heritage. 2. Orbital capability — The Exploration Company partnership puts Ecoatoms in the orbital regime, not just suborbital. 3. Institutional depth — Massa's appointment as Director of UNR Aerospace & Defense Academy, SSBCI VC backing, and NCAR lab access indicate institutional support beyond grant funding.
Remaining skepticism: Still $0 in USASpending contracts. The SSBCI VC investment amount is undisclosed. No revenue is visible. The $1.13M Aerospace & Defense Academy gift is institutional, not Ecoatoms revenue. The company is building capabilities but hasn't yet generated visible commercial traction.
TRL ambition gap (revised): ANIMA's TRL 2→8 target is more credible now that the onboard computer has flight heritage. HERMES TRL 4→9 remains very ambitious.
Fortune 500 clients claim: The UNR article mentions "multiple launches scheduled for 2025 involving suborbital and orbital rockets serving NASA and Fortune 500 clients." The Fortune 500 reference is unverified but suggests commercial customers exist beyond NASA.
Time Dimension¶
- Company founded: 2020
- Biosensor project start: Dec 2021
- Flight 1 (suborbital): NS-24, Dec 19, 2023 — biosensors + medical devices
- ANIMA project start: Jun 2024
- TechLeap Prize (ANIMA): 2024
- HERMES project start: Jun 2025
- TechLeap Prize (HERMES): 2025
- Flight 2 (orbital): Transporter-14 / Nyx, Jun 23, 2025 — biological organisms
- Flight 3 (suborbital): NS-35, Aug 23, 2025 — A.R.E.S. 432 biosensors + ANIMA onboard computer
- Post-flight analysis: ongoing (TechPort TRL still at 4 as of Feb 2026)
- HERMES flight target: Summer 2026
- Commercial revenue: none visible
Cross-References¶
- Related archetype: Early-stage multi-project startup (compare Space Lab Technologies — also multi-SBIR, LILYPOND at NASA, no revenue)
- TechLeap Prize pattern: See Juno Propulsion, SpaceWorks/TVA — Prize + FO = double-backed
- Biosensor/diagnostic space: Compare MGH NINscan, Massachusetts General Hospital — medical instrumentation for space
Investigated: Session 15 (2026-04-06) | Updated: Session 72 (2026-04-07)
Sources: TechPort [106609, 184148, 158510], NASA FO website (TechLeap winners), Factories in Space database, NASA Space Act Agreements list, Blue Origin NS-24 & NS-35 mission pages, SpaceCom 2026 speaker bio, OIST Japan event listing, UNR Nevada Today (2024), The Exploration Company/Transporter-14, USASpending (no results)